SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-153419
Filing Date
2021-05-06
Accepted
2021-05-06 16:56:42
Documents
75
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d148297d10q.htm   iXBRL 10-Q 856259
2 EX-31.1 d148297dex311.htm EX-31.1 10361
3 EX-31.2 d148297dex312.htm EX-31.2 10375
4 EX-32.1 d148297dex321.htm EX-32.1 4127
5 EX-32.2 d148297dex322.htm EX-32.2 4140
11 GRAPHIC g148297g0501050031950.jpg GRAPHIC 3127
  Complete submission text file 0001193125-21-153419.txt   4567647

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tmxd-20210331.xsd EX-101.SCH 50540
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tmxd-20210331_cal.xml EX-101.CAL 37388
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmxd-20210331_def.xml EX-101.DEF 161001
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmxd-20210331_lab.xml EX-101.LAB 323497
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmxd-20210331_pre.xml EX-101.PRE 260374
12 EXTRACTED XBRL INSTANCE DOCUMENT d148297d10q_htm.xml XML 714869
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-00100 | Film No.: 21898714
SIC: 2834 Pharmaceutical Preparations